Clinical Implications of Assessing Coronary Flow Velocity Reserve and Plasma Endothelin-1 in Hypertensive Patients

Abstract

Previous reports have indicated that hypertensive patients who have angina-like chest pain and normal coronary arteriograms have reduced coronary flow velocity reserve (CFVR) levels. In addition, elevated plasma endothelin-1 (ET-1) levels have been reported to be associated with microvascular angina. The purpose of this study was to evaluate the plasma ET-1 levels and CFVR in patients with chest pain but without coronary artery disease (CAD). A total of 66 patients were included in this study. CAD was ruled out by exercise stress test or coronary angiogram. Plasma ET-1 and CFVR measurements were performed in patients with (n=35) and without (n=31) a history of angina-like chest pain. CFVR was measured using adenosine-triphosphate stress transthoracic Doppler echocardiography. The mean ET-1 level was significantly higher and the CFVR was significantly lower in patients in the symptomatic group than in those in the asymptomatic group (ET-1: 3.85±1.24 pg/ml vs. 2.98±1.27 pg/ml, CFVR: 2.26±0.48 vs. 2.77±0.11, respectively). Plasma ET-1 level and CFVR were significantly correlated with each other (−r=0.265, p=0.033). Age, blood pressure, cardiovascular risk factors, and left ventricular mass index were similar between the two groups. The results of multiple regression analysis indicate that age (p=0.008) and plasma ET-1 concentration (p=0.031) had statistically independent associations with CFVR. Attenuated CFVR in the symptomatic hypertensive patients was associated with endothelial dysfunction, which results in elevated plasma ET-1 levels. The link between these two parameters may play a role in the genesis of chest pain in hypertensive patients without CAD.

References

  1. 1

    Opherk D, Mall G, Zebe H, et al: Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69: 1–7.

  2. 2

    Brush JE Jr, Cannon RO 3rd, Schenke WH, et al: Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302–1307.

  3. 3

    Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A : Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 2000; 35: 1654–1660.

  4. 4

    Panza JA : Myocardial ischemia and the pains of the heart. N Engl J Med 2002; 346: 1934–1935.

  5. 5

    Bugiardini R, Pozzati A, Ottani F, Morgagni GL, Puddu P : Vasotonic angina: a spectrum of ischemic syndromes involving functional abnormalities of the epicardial and microvascular coronary circulation. J Am Coll Cardiol 1993; 22: 417–425.

  6. 6

    Cox ID, Botker HE, Bagger JP, Sonne HS, Kristensen BO, Kaski JC : Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms. J Am Coll Cardiol 1999; 34: 455–460.

  7. 7

    Hoffmann E, Assennato P, Donatelli M, Colletti I, Valenti TM : Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms. Am Heart J 1998; 135: 684–688.

  8. 8

    Kaski JC, Cox ID, Crook JR, et al, Coronary Artery Disease Research Group : Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries. Am Heart J 1998; 136: 412–417.

  9. 9

    Kaski JC, Elliott PM, Salomone O, et al: Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J 1995; 74: 620–624.

  10. 10

    Artigou JY, Salloum J, Carayon A, et al: Variations in plasma endothelin concentrations during coronary spasm. Eur Heart J 1993; 14: 780–784.

  11. 11

    Hozumi T, Yoshida K, Akasaka T, et al: Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 1998; 32: 1251–1259.

  12. 12

    Takiuchi S, Rakugi H, Fujii H, et al: Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease. Hypertens Res 2003; 26: 945–951.

  13. 13

    Takiuchi S, Rakugi H, Masuyama T, et al: Hypertension attenuates the efficacy of hypoglycemic therapy for preserving coronary flow reserve in patients with type 2 diabetes. Hypertens Res 2002; 25: 893–900.

  14. 14

    Hozumi T, Yoshida K, Ogata Y, et al: Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998; 97: 1557–1562.

  15. 15

    Branwald E : The history. in Branwald E, Zipes DP, Libby P ( eds): Heart Disease, 6th ed. Philadelphia: W.B. Saunders Co., 2001, pp 30–31.

  16. 16

    Matsumura Y, Hozumi T, Watanabe H, et al: Department of internal cut-off value of coronary flow velocity reserve by transthoracic Doppler echocardiography for diagnosis of significant left anterior descending artery stenosis in patients with coronary risk factors. Am J Cardiol 2003; 92: 1389–1393.

  17. 17

    Devereux RB, Reichek N : Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.

  18. 18

    Palombo C, Kozakova M, Magagna A, et al: Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients. J Hypertens 2000; 18: 453–459.

  19. 19

    Kozàkovà M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A : Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29: 551–559.

  20. 20

    Antony I, Nitenberg A, Foult JM, Aptecar E : Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol 1993; 22: 514–520.

  21. 21

    Sasaki O, Hamada M, Hiwada K : Effects of coronary blood flow on left ventricular function in essential hypertensive patients. Hypertens Res 2000; 23: 239–245.

  22. 22

    Maseri A, Crea F, Kaski JC, Crake T : Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991; 17: 499–506.

  23. 23

    Piatti P, Fragasso G, Monti LD, et al: Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol 1999; 34: 1452–1460.

  24. 24

    Takiuchi S, Fujii H, Kamide K, et al: Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. Am J Hypertens 2004; 9: 802–808.

  25. 25

    Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415.

  26. 26

    Miyauchi T, Tomobe Y, Shiba R, et al: Involvement of endothelin in the regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells. Circulation 1990; 81: 1874–1880.

  27. 27

    MacCarthy PA, Pegge NC, Prendergast BD, Shah AM, Groves PH : The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone. J Am Coll Cardiol 2001; 37: 137–143.

  28. 28

    Cox ID, Salomone O, Brown SJ, Hann C, Kaski JC : Serum endothelin levels and pain perception in patients with cardiac syndrome X and in healthy controls. Am J Cardiol 1997; 80: 637–640.

  29. 29

    Huelmos A, Garcia Velloso MJ, Maceira A : Myocardial perfusion reserve and endothelin plasmatic levels in asymptomatic patients with cardiovascular risk factors. Eur Heart J 1997; 18 ( Suppl): 435 ( Abstract).

  30. 30

    Cannon RO 3rd, Balaban RS : Chest pain in women with normal coronary angiograms. N Engl J Med 2000; 342: 885–887.

  31. 31

    Merz CN, Kelsey SF, Pepine CJ, et al: The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999; 33: 1453–1461.

  32. 32

    Rosano GM, Collins P, Kaski JC, Lindsay DC, Sarrel PM, Poole-Wilson PA : Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 1995; 16: 610–614.

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hideki Fujii.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fujii, H., Takiuchi, S., Kamide, K. et al. Clinical Implications of Assessing Coronary Flow Velocity Reserve and Plasma Endothelin-1 in Hypertensive Patients. Hypertens Res 28, 911–916 (2005). https://doi.org/10.1291/hypres.28.911

Download citation

Keywords

  • coronary flow velocity reserve
  • endothelin-1
  • endothelial function
  • hypertension
  • coronary artery disease

Further reading